HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KIDINS220
kinase D interacting substrate 220
Chromosome 2 Β· 2p25.1
NCBI Gene: 57498Ensembl: ENSG00000134313.17HGNC: HGNC:29508UniProt: A0A8I5QJC0
118PubMed Papers
22Diseases
0Drugs
54Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingmembranePDZ domain bindingpositive regulation of neuron projection developmentspastic paraplegia, intellectual disability, nystagmus, and obesityventriculomegaly and arthrogryposisneurodegenerative diseasegenetic disorder
✦AI Summary

KIDINS220 is a multifunctional scaffold protein that serves as a critical regulator of phosphate homeostasis and neurotrophin signaling. Its primary function involves forming a complex with the phosphate exporter XPR1, where KIDINS220 stabilizes XPR1 in a closed conformation and regulates its cellular localization and activity 1. The XPR1-KIDINS220 complex works synergistically with inositol pyrophosphates to control phosphate efflux, with KIDINS220 acting as a safeguard mechanism that prevents uncontrolled phosphate export 23. Mechanistically, KIDINS220 promotes sustained MAP-kinase signaling by neurotrophins through Rap1-dependent pathways and serves as a docking site for various signaling complexes involved in neuronal differentiation and survival 4. The protein also regulates cellular metabolism, as decreased KIDINS220 expression inhibits AMPK phosphorylation and reduces glycolysis in nucleus pulposus cells under mechanical stress 5. Disease relevance is significant, as heterozygous pathogenic variants cause SINO syndrome (spastic paraplegia, intellectual disability, nystagmus, and obesity), with truncated proteins showing mislocalization and trans-dominant negative effects 6. Additionally, KIDINS220 accumulates with tau in Alzheimer's disease, where GSK3Ξ²/PP1 imbalance affects its calpain processing 7. Clinically, the XPR1-KIDINS220 complex represents a therapeutic vulnerability in ovarian cancer due to phosphate dysregulation 1.

Sources cited
1
KIDINS220 forms a complex with phosphate exporter XPR1 and is required for its proper cellular localization and activity
PMID: 35437317
2
XPR1-KIDINS220 complex works synergistically with inositol pyrophosphates to regulate phosphate export
PMID: 40128258
3
KIDINS220 stabilizes XPR1 in closed conformation and acts as safeguard mechanism for stepwise phosphate regulation
PMID: 40858110
4
KIDINS220 promotes sustained MAP-kinase signaling and serves as scaffold for neurotrophin signaling complexes
PMID: 28849114
5
Decreased KIDINS220 expression inhibits AMPK phosphorylation and reduces cellular glycolysis
PMID: 39952914
6
Heterozygous pathogenic KIDINS220 variants cause SINO syndrome with truncated proteins showing trans-dominant negative effects
PMID: 39033379
7
KIDINS220 accumulates with tau in Alzheimer's disease due to altered GSK3Ξ²/PP1-mediated calpain processing
PMID: 23118350
Disease Associationsβ“˜22
spastic paraplegia, intellectual disability, nystagmus, and obesityOpen Targets
0.79Strong
ventriculomegaly and arthrogryposisOpen Targets
0.70Strong
neurodegenerative diseaseOpen Targets
0.44Moderate
genetic disorderOpen Targets
0.39Weak
developmental disorder of mental healthOpen Targets
0.37Weak
Limb joint contractureOpen Targets
0.37Weak
neuroinflammatory disorderOpen Targets
0.37Weak
hereditary spastic paraplegiaOpen Targets
0.35Weak
exostosisOpen Targets
0.33Weak
response to xenobiotic stimulusOpen Targets
0.30Weak
cerebral palsyOpen Targets
0.27Weak
Kabuki syndrome 1Open Targets
0.27Weak
ovarian neoplasmOpen Targets
0.23Weak
major salivary gland cancerOpen Targets
0.22Weak
endometrial carcinomaOpen Targets
0.15Weak
ovarian carcinomaOpen Targets
0.15Weak
Intellectual disabilityOpen Targets
0.15Weak
obesityOpen Targets
0.14Weak
melanomaOpen Targets
0.10Suggestive
neuroblastomaOpen Targets
0.09Suggestive
Spastic paraplegia, intellectual disability, nystagmus, and obesityUniProt
Ventriculomegaly and arthrogryposisUniProt
Pathogenic Variants54
NM_020738.4(KIDINS220):c.3374dup (p.Tyr1125Ter)Pathogenic
KIDINS220-related disorder|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1125
NM_020738.4(KIDINS220):c.3991G>T (p.Glu1331Ter)Pathogenic
Spastic paraplegia, intellectual disability, nystagmus, and obesity|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1331
NM_020738.4(KIDINS220):c.4417dup (p.Leu1473fs)Pathogenic
not provided|Spastic paraplegia, intellectual disability, nystagmus, and obesity
β˜…β˜…β˜†β˜†2024β†’ Residue 1473
NM_020738.4(KIDINS220):c.3528+1_3528+7delLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_020738.4(KIDINS220):c.3726_3733del (p.Ile1242fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1242
NM_020738.4(KIDINS220):c.3991delinsAGCCCTACACACTCAAC (p.Glu1331fs)Pathogenic
Spastic paraplegia, intellectual disability, nystagmus, and obesity
β˜…β˜†β˜†β˜†2024β†’ Residue 1331
NM_020738.4(KIDINS220):c.2137_2145del (p.Gln713_Leu715del)Pathogenic
Ventriculomegaly and arthrogryposis|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 713
NM_020738.4(KIDINS220):c.856C>T (p.Arg286Ter)Likely pathogenic
Spastic paraplegia, intellectual disability, nystagmus, and obesity
β˜…β˜†β˜†β˜†2024β†’ Residue 286
NM_020738.4(KIDINS220):c.4388C>G (p.Ser1463Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1463
NM_020738.4(KIDINS220):c.4295del (p.Glu1432fs)Likely pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2024β†’ Residue 1432
NM_020738.4(KIDINS220):c.3949G>T (p.Glu1317Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1317
NM_020738.4(KIDINS220):c.3934G>T (p.Glu1312Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1312
NM_020738.4(KIDINS220):c.3874dup (p.Ser1292fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1292
NM_020738.4(KIDINS220):c.4177C>T (p.Gln1393Ter)Pathogenic
Spastic paraplegia, intellectual disability, nystagmus, and obesity
β˜…β˜†β˜†β˜†2024β†’ Residue 1393
NM_020738.4(KIDINS220):c.4213_4216dup (p.Ile1406fs)Likely pathogenic
Spastic paraplegia, intellectual disability, nystagmus, and obesity
β˜…β˜†β˜†β˜†2023β†’ Residue 1406
NM_020738.4(KIDINS220):c.1263_1264del (p.Gln421fs)Pathogenic
not provided|KIDINS220-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 421
NM_020738.4(KIDINS220):c.3718-12A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_020738.4(KIDINS220):c.4053+2dupLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_020738.4(KIDINS220):c.3436_3443dup (p.Arg1149fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 1149
NM_020738.4(KIDINS220):c.4054-1G>CLikely pathogenic
KCNA1-related disorder
β˜…β˜†β˜†β˜†2023
View on ClinVar β†—
Related Genes
NTRK1Protein interaction99%CRKLProtein interaction96%CRKProtein interaction92%SNX27Protein interaction73%PRKD3Protein interaction72%XPR1Protein interaction64%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
83%
Heart
74%
Ovary
70%
Lung
44%
Liver
27%
Gene Interaction Network
Click a node to explore
KIDINS220NTRK1CRKLCRKSNX27PRKD3XPR1
PROTEIN STRUCTURE
Preparing viewer…
PDB9JXQ Β· 3.44 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.45Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.34 [0.26–0.45]
RankingsWhere KIDINS220 stands among ~20K protein-coding genes
  • #3,997of 20,598
    Most Researched118 Β· top quartile
  • #1,258of 5,498
    Most Pathogenic Variants54 Β· top quartile
  • #2,530of 17,882
    Most Constrained (LOEUF)0.45 Β· top quartile
Genes detectedKIDINS220
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer.
PMID: 35437317
Nat Cancer Β· 2022
1.00
2
Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate.
PMID: 40128258
Nat Commun Β· 2025
0.90
3
Matrix stiffness regulates nucleus pulposus cell glycolysis by MRTF-A-dependent mechanotransduction.
PMID: 39952914
Bone Res Β· 2025
0.80
4
Kidins220 and tumour development: Insights into a complexity of cross-talk among signalling pathways (Review).
PMID: 28849114
Int J Mol Med Β· 2017
0.70
5
KIDINS220 and InsP8 safeguard the stepwise regulation of phosphate exporter XPR1.
PMID: 40858110
Mol Cell Β· 2025
0.60